Evidence map›Paper›PMID 27928757›Full record

Observational studyAdvances in therapy2017

Efficacy of a Novel Prefilled, Single-Use, Needle-Free Device (Zeneo

Marc Bardou, Maxime Luu, Paul Walker, Christophe Auriel, Xavière Castano

Open access · hybridAbstract readObservational Study
In one paragraph

Observational study in Advances in therapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Alternatives to Injectable Adrenaline for Treating Anaphylaxis.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2025
    Review
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Marc BardouClinical Investigation Center (CIC) INSERM 1432, Dijon University Hospital, Dijon, France. Marc.bardou@u-bourgogne.fr.
Maxime LuuClinical Investigation Center (CIC) INSERM 1432, Dijon University Hospital, Dijon, France.
Paul WalkerLe2i, UMR CNRS 6306 UFR Sciences de Santé Université de Bourgogne, Franche-Comté, Dijon, France.
Christophe AurielCrossject, 60 L Avenue du 14 Juillet, 21300, Chenôve, France.
Xavière CastanoCrossject, 60 L Avenue du 14 Juillet, 21300, Chenôve, France.
Crossject (France) · FRCentre d’Investigation Clinique 1436Centre National de la Recherche Scientifique · FRMaison des Sciences de l’Homme de Dijon · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIt is recognized that, as a result of variation in tissue anatomy, current auto-injectors may have insufficient needle length to achieve successful intramuscular agent delivery in a number of patients. The Zeneo

methodsThis was a prospective single-center study in healthy adult volunteers, in whom each received a single injection of saline into the anterolateral thigh. Using sequential MRI scans, we measured skin-to-muscle distance (STMD) agent delivery depth, and the success of IM agent penetration. Device dynamic pressure measurements were also recorded.

resultsResults are reported for 37 subjects with evaluable MRI scans; 19 men, 18 women; mean age 38 years (range 20-58); mean BMI 27.0 kg/m

conclusionUse of the Zeneo

fundingCrossject.

Indexed as

NeedlesAdultBody Mass IndexFemaleHumansInjections, IntramuscularMaleMiddle AgedMuscle, SkeletalProspective StudiesSkinThighAnaphylaxisAuto-injectorEpinephrine/adrenalineIntramuscularNeedle lengthSkin-to-muscle depth

Identifiers

PMID27928757
PMCPMC5216060
OpenAlexW2559895085

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.